Epidemiologic and molecular prognostic review of glioblastoma
about
The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic ReviewCytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment optionsAdvance Care Planning in Glioblastoma PatientsTelomere maintenance and the etiology of adult gliomaSomatic mutations associated with MRI-derived volumetric features in glioblastomaRegulation of microglial survival and proliferation in health and diseases.Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience.Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer DatabaseEmerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance.Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in GlioblastomaGlioblastoma Multiforme Cancer Stem Cells Express Components of the Renin-Angiotensin SystemAssociation between SET expression and glioblastoma cell apoptosis and proliferation.Glioblastoma: Overview of Disease and Treatment.New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us.Glioblastoma: pathology, molecular mechanisms and markers.Irinotecan-based regimens for recurrent glioblastoma multiforme: [corrected] a systematic review.Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma.Advances in HSP27 and HSP90-targeting strategies for glioblastoma.Quantitative Imaging Biomarkers for Risk Stratification of Patients with Recurrent Glioblastoma Treated with Bevacizumab.AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic modelsAn independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation.Harnessing nanomedicine for therapeutic intervention in glioblastoma.Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and TreatmentRole and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma.The Risk of Glioblastoma with TNF Inhibitors.MR Fingerprinting of Adult Brain Tumors: Initial Experience.Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry.Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis.Analysis of DTI-Derived Tensor Metrics in Differential Diagnosis between Low-grade and High-grade Gliomas.Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.The Effects of Silica Nanoparticles on Apoptosis and Autophagy of Glioblastoma Cell Lines.Central nervous system tumors: Spotlight on IndiaSuppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.
P2860
Q26752321-3B593AF9-22FD-4AD8-9760-9F4B481DEC37Q26996612-F6FDA8C3-866B-405E-B09A-976F37BF7280Q28067320-C4F181E0-50EF-41C0-939A-E5AA925381B3Q28084275-525BEBCB-F69C-476E-86EE-AD7A58371A72Q28607337-471171BF-DA82-484D-899D-C58E52305980Q30360331-9B81493B-AAAC-40C2-A658-72C45E3C5EC7Q33559128-35588370-AC7C-4E96-AA93-2BB01ABA4DC4Q33612877-5D432FFB-1774-4E13-B1D1-0CA16ED73CFAQ33737472-ECE806FC-1586-4610-8507-0C6069F3F6BCQ33775341-1218AD4F-9919-4E86-AF3A-6CA50F8CBE5EQ34974398-3F3B7BB0-66FB-45BC-9F19-CF6D4CF19CEAQ36097869-92FEEB55-7167-4E32-8B6E-13CC556F8CAEQ37284738-E8F03F3A-E513-4C21-B9B1-FE4A3D1BC2F5Q37287605-20D2E622-52F5-45C5-B80C-F78237479BE7Q37441791-BA60F997-FDD0-4AA9-94A8-9F53215DBBBAQ37665446-BAED265A-E282-466E-833A-8C3C29A4025BQ38430287-10451070-9209-49F0-9C51-9A049A95A57AQ38460865-71A485E7-3D1D-4DD0-802E-D4041E018E1FQ38607859-E998DF14-857F-4C8B-BA3D-63BAF0CD8D29Q38629781-3920FFE8-9964-4BB0-A678-03EF70ECAF5AQ38696529-100DA982-AE45-47A6-A610-9426262AD001Q38722149-C8B4AF89-4C66-4ED9-9653-F712911CE590Q38789124-7F269077-DF54-4D40-BEE9-F346EC7B6C61Q38813184-6A7B7CF1-9C09-4276-A64C-0C75F2BA6F3EQ38814455-20D75448-C276-436C-AB2F-5201E7CC0C5CQ38815311-D78EC207-C16E-4D66-BC64-C4BA7AAFA8BBQ38815443-26DD84BA-9608-4016-9C00-F5F71EF7F8AAQ38862946-057501A9-EBD8-4E7A-87E3-302CCA6801BEQ38870220-7F286C8D-D338-437D-B903-7852EBE2DF18Q39152200-FD0044FE-924F-4C43-9BE7-F0FF78CA8E18Q39428273-4BC8328D-3920-4A1D-BBED-82D063CE3122Q39956333-8CBE982A-700D-4CDE-9A64-222784E98FCAQ40402415-47E52A52-CCE7-47B6-87A3-06FD96F93903Q40450600-EE61FD96-66F8-44D8-AC13-BD247B5FDABBQ41110170-1C05063B-394A-46DD-A6CF-577004EB8B95Q41341615-2894B710-0975-45CA-811D-E777E0BAA0AEQ41438064-1F2304B0-6486-4467-AB24-3D7F88CD684EQ41553420-6FF550EE-01BC-433D-871C-AED687545BF2Q42345506-B38BD632-6340-4634-B751-5922075175EAQ43400612-4DD4DF93-2EFE-466B-9357-A39CC7D67DC5
P2860
Epidemiologic and molecular prognostic review of glioblastoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Epidemiologic and molecular prognostic review of glioblastoma
@ast
Epidemiologic and molecular prognostic review of glioblastoma
@en
Epidemiologic and molecular prognostic review of glioblastoma
@nl
type
label
Epidemiologic and molecular prognostic review of glioblastoma
@ast
Epidemiologic and molecular prognostic review of glioblastoma
@en
Epidemiologic and molecular prognostic review of glioblastoma
@nl
prefLabel
Epidemiologic and molecular prognostic review of glioblastoma
@ast
Epidemiologic and molecular prognostic review of glioblastoma
@en
Epidemiologic and molecular prognostic review of glioblastoma
@nl
P2093
P2860
P3181
P1476
Epidemiologic and molecular prognostic review of glioblastoma
@en
P2093
Craig Horbinski
Donita D Lightner
Jigisha P Thakkar
John L Villano
Therese A Dolecek
P2860
P304
P3181
P356
10.1158/1055-9965.EPI-14-0275
P407
P577
2014-07-22T00:00:00Z